Geode Capital Management LLC Has $13.17 Million Stock Position in agilon health, inc. (NYSE:AGL)

Geode Capital Management LLC increased its stake in shares of agilon health, inc. (NYSE:AGL) by 0.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,928,724 shares of the company’s stock after purchasing an additional 35,207 shares during the period. Geode Capital Management LLC owned approximately 1.68% of agilon health worth $13,168,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in AGL. Charles Schwab Investment Management Inc. increased its holdings in shares of agilon health by 49.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after acquiring an additional 1,498,524 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after buying an additional 1,083,492 shares during the period. Alberta Investment Management Corp bought a new position in agilon health in the fourth quarter valued at approximately $1,564,000. Vanguard Group Inc. boosted its holdings in shares of agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after buying an additional 272,787 shares during the period. Finally, Barclays PLC raised its holdings in shares of agilon health by 21.2% during the third quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock worth $4,830,000 after acquiring an additional 214,830 shares during the period.

Analysts Set New Price Targets

AGL has been the subject of a number of research reports. Sanford C. Bernstein upgraded agilon health from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Robert W. Baird reduced their price target on agilon health from $6.00 to $5.00 and set a “neutral” rating for the company in a research report on Tuesday, April 15th. Royal Bank of Canada lifted their price objective on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a report on Wednesday, February 26th. TD Cowen raised their target price on shares of agilon health from $3.50 to $6.00 and gave the company a “hold” rating in a research report on Tuesday, April 15th. Finally, Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, agilon health presently has an average rating of “Hold” and a consensus price target of $4.60.

agilon health Trading Up 3.5 %

Shares of agilon health stock opened at $4.14 on Tuesday. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a market capitalization of $1.71 billion, a price-to-earnings ratio of -4.40 and a beta of 0.38. The business has a fifty day simple moving average of $4.15 and a two-hundred day simple moving average of $3.12. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.